Key facts
- This page summarizes Deborah Turner Kochevar's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2024, 17:14.
Deborah Turner Kochevar - 13 May 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- Director
- Issuer ticker
- CRL
- Reported as of
- 13 May 2024
- Net transaction value
- +$427,127
- SEC form
- 4
- Accepted by SEC
- 15 May 2024, 17:14:39 UTC
- Prior SEC filing
- 04 Dec 2023
- Next SEC filing
- 03 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Deborah T. Kochevar
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Deborah Turner Kochevar filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 15 May 2024.
Change
- Previous filing in this sequence was filed on 04 Dec 2023.
- Current net transaction value: +$427,127.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Award
- Transaction value
- $127,681
- Shares
- +559
- Change %
- +7.6%
- Price
- $228.41
- Shares after
- 7,894
- Date
- 13 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $299,446
- Shares
- +1,311
- Change %
- Price
- $228.41
- Shares after
- 1,311
- Date
- 13 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,311
- Exercise price
- $228.41
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
Footnote F2
The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.